Incorporation of Retinal Arteriolosclerosis into Risk Stratification of Blood Pressure Category According to the 2017

Satoshi Matsuoka1,2, Hidehiro Kaneko1,3, Tatsuya Kamon1

  • 1The Department of Cardiovascular Medicine, The University of Tokyo.

Insights

Retinal arteriolosclerosis (RA) can improve cardiovascular disease (CVD) risk assessment in individuals classified by the 2017 ACC/AHA Blood Pressure (BP) guideline. Adding RA assessment enhances risk stratification, especially for stage 1 hypertension.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) risk stratification relies on guidelines like the 2017 ACC/AHA Blood Pressure (BP) guideline.
  • Retinal arteriolosclerosis (RA) is a potential indicator of systemic vascular damage.
  • The utility of RA in refining CVD risk stratification within current BP guidelines is not fully established.

Purpose of the Study:

  • To investigate if retinal arteriolosclerosis (RA) can enhance cardiovascular disease (CVD) risk stratification.
  • To evaluate RA's role in individuals categorized by the 2017 ACC/AHA Blood Pressure (BP) guideline.
  • To determine if RA presence modifies CVD risk associated with different BP categories.

Main Methods:

  • A large cohort of 291,522 participants without prior CVD or BP medication use was analyzed.
  • Participants were categorized into six groups based on BP levels (normal/elevated, stage 1 hypertension, stage 2 hypertension) and presence or absence of RA (Keith-Wagener-Barker grade ≥ 1).
  • Multivariable Cox regression models assessed the association between BP categories, RA, and incident CVD events (MI, angina, stroke, HF) over a mean follow-up of 1,223 days.

Main Results:

  • The risk of CVD events increased with higher BP categories, and this risk was significantly amplified by the presence of RA.
  • Individuals with stage 1 hypertension and RA had a substantially higher hazard ratio for myocardial infarction (MI) compared to those with normal BP and no RA.
  • Similar associations between RA and increased CVD risk were observed for stroke and heart failure (HF).

Conclusions:

  • The presence of retinal arteriolosclerosis (RA) significantly modifies cardiovascular disease (CVD) risk stratification.
  • Incorporating RA assessment can improve the accuracy of risk prediction for individuals under the 2017 ACC/AHA BP guideline.
  • RA assessment is particularly valuable for refining risk in individuals classified with stage 1 hypertension.
Abstract

Related Concept Videos

Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
649
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
148
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
77
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
747
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
147